On the recordDecember 6, 2017
Frankly, it didn't even come close, and that's why today we're reintroducing the National Biomedical Research Act, which provides $50 billion in new funding for the NIH and for the FDA.
Source
congress.govFrankly, it didn't even come close, and that's why today we're reintroducing the National Biomedical Research Act, which provides $50 billion in new funding for the NIH and for the FDA.
Warren criticizes the Cures Act and proposes new funding for NIH and FDA.
Share
More from Elizabeth Warren
I urge DOD to flatly prohibit vertical integration in the next TRICARE pharmacy contract. A vertically integrated PBM has every incentive to line its own pockets, and DOD should not be using taxpayer dollars to fund these schemes.
This money appears to have been spent with no explanation provided as to how, or by who, or how it may be related to the library.
The gaps in these new disclosure documents reveal the urgent need for this legislation.